Baicalein protects rat cardiomyocytes from hypoxia/reoxygenation damage via a prooxidant mechanism

被引:88
作者
Woo, AYH [1 ]
Cheng, CHK [1 ]
Waye, MMY [1 ]
机构
[1] Chinese Univ Hong Kong, Croucher Lab Human Genom, Dept Biochem, Shatin, Hong Kong, Peoples R China
关键词
baicalein; prooxidant; hydrogen peroxide; cardioprotection; hypoxia; reoxygenation;
D O I
10.1016/j.cardiores.2004.09.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Baicalin and its aglycone baicalein are the major flavonoid components of the root of Scutellaria baicalensis. Recent studies have shown that they can attenuate oxidative stress in various in vitro models as they possess potent antioxidant activities. This study investigated alternative protective mechanisms of baicalein in a cardiomyocyte model. Methods: Neonatal rat cardiomyocytes pretreated with the test compound were subjected to hypoxia/rcoxygenation. The extent of cellular damage was accessed by the amount of released lactate dehydrogenase. Results: Pretreatment with baicalein up to 10 muM reduced lactate dehydrogenase release significantly (P < 0.001), while pretreatment with baicalin up to 100 muM was ineffective. The cardioprotective effect of baicalein is not due to its antioxidant effect, because an adverse effect rather than a protective effect was observed when baicalein was present during hypoxia. Cotreatment with N-acetylcysteine attenuated the protective effect of baicalein and concomitantly increased intracellular reactive oxygen species level and the cytotoxic effect of baicalein, but N-acetylcysteine alone did not have such effects. In addition, cotreatment with catalase, but not superoxide dismutase or mannitol, reversed the cardioprotective effect of baicalein, suggesting the involvement of hydrogen peroxide in the cardioprotective mechanism. The NAD(P)H:quinone oxidoreductase inhibitors dicoumarol and chrysin also abolished the cardioprotective effect of baicalein. While pretreatment with baicalein did not increase antioxidant enzyme activities, it alleviated calcium accumulation in cardiomyocytes undergoing simulated ischemia. Conclusion: These results highlight the important role of hydrogen peroxide produced during the auto-oxidation of baicalein in the cardioprotective effect of baicalein. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:244 / 253
页数:10
相关论文
共 50 条
[1]  
Aebi H, 1984, Methods in enzymology, V105, P121, DOI [10.1016/S0076-6879(84)05016-3, DOI 10.1016/S0076-6879(84)05016-3]
[2]  
Anderson M., 1996, FREE RADICALS PRACTI, P213
[3]   Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium [J].
Baines, CP ;
Goto, M ;
Downey, JM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (01) :207-216
[4]   Characterization of the calcium overload in cultured neonatal rat cardiomyocytes under metabolic inhibition [J].
Barrigon, S ;
Wang, SY ;
Ji, XW ;
Langer, GA .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (06) :1329-1337
[5]   SUPEROXIDE DISMUTASE - IMPROVED ASSAYS AND AN ASSAY APPLICABLE TO ACRYLAMIDE GELS [J].
BEAUCHAM.C ;
FRIDOVIC.I .
ANALYTICAL BIOCHEMISTRY, 1971, 44 (01) :276-&
[6]  
Boston DR, 1998, J PHARMACOL EXP THER, V285, P716
[7]   Mitochondrial function in response to cardiac ischemia-reperfusion after oral treatment with quercetin [J].
Brookes, PS ;
Digerness, SB ;
Parks, DA ;
Darley-Usmar, V .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (11) :1220-1228
[8]   HYDROGEN-PEROXIDE CYTOTOXICITY IN CULTURED CARDIAC MYOCYTES IS IRON-DEPENDENT [J].
BYLER, RM ;
SHERMAN, NA ;
WALLNER, JS ;
HORWITZ, LD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (01) :H121-H127
[9]   Mitochondrial KATP channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation [J].
Carroll, R ;
Gant, VA ;
Yellon, DM .
CARDIOVASCULAR RESEARCH, 2001, 51 (04) :691-700
[10]   Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cells [J].
Chou, CC ;
Pan, SL ;
Teng, CM ;
Guh, JH .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 19 (05) :403-412